U.S. equity futures opened the week on the back foot as investors reacted to an intensifying conflict in the Middle East and shifted away from higher-risk positions at the outset of a busy trading week.
Several notable premarket movers reflected a market split between sectors viewed as havens or beneficiaries of geopolitical stress and those exposed to travel disruption, operational shocks, or weaker earnings trends.
Berkshire Hathaway (NYSE:BRKb) shares dropped 1.3% in premarket action after the conglomerate disclosed a nearly 30% decline in fourth-quarter operating profit from a year earlier, with insurance underwriting identified as a drag on results.
Paramount Skydance (NASDAQ:PSKY) advanced 5.2% after a joint statement from Warner Bros Discovery (NASDAQ:WBD) following the market close on Friday announced the two companies had signed a definitive merger agreement.
Amazon (NASDAQ:AMZN) shares fell 2.4% after Amazon Web Services reported it was addressing a disruption in the United Arab Emirates. The issue followed an incident in which unidentified "objects" struck one of its data centers, causing a fire and a power outage.
Norwegian Cruise Line (NYSE:NCLH) plunged 7% after management projected full-year profit below analysts' expectations, citing steep costs that offset durable demand for premium sea vacations.
Energy majors rallied sharply on the back of higher crude prices tied to the regional escalation. Exxon Mobil (NYSE:XOM) climbed 4.7% while Chevron (NYSE:CVX) added 3.9%, as oil market participants reacted to the heightened geopolitical risk.
Defense names drew buying interest amid reports of broader U.S.-Israel military action against Iran over the weekend, boosting Lockheed Martin (NYSE:LMT) by 5.4% in premarket trading.
Precious metals also benefitted from safe-haven flows. Harmony Gold Mining (NYSE:HMY) rose 1.6% as gold prices climbed in response to the conflict escalation.
Airlines posted steep losses, reflecting operational disruption and regional flight impacts related to U.S. and Israeli military actions. American Airlines (BMV:AAL), Delta Air Lines (NYSE:DAL) and United Airlines (NASDAQ:UAL) each fell by more than 4% in early trading.
Biotech Uniqure (NASDAQ:QURE) saw a dramatic 37% decline after disclosing that the U.S. Food and Drug Administration rejected its proposed regulatory pathway for an investigational gene therapy targeting Huntington's disease.
The premarket landscape highlights the market's sensitivity to geopolitical developments and company-specific news alike. Energy and defense stocks jumped on perceived demand and price effects, while travel-related and certain tech-exposed names were punished for cost pressures or operational interruptions.